PNV 1.26% $2.41 polynovo limited

Ann: Director Share Purchase - David Williams, page-75

  1. 5,850 Posts.
    lightbulb Created with Sketch. 17248
    Dermal matrices are already being used in shoulder repair. Pictures of one technique can be found here.

    The authors of this paper state that the risks associated with this procedure include those that come with using normal dermal matrix materials - the risk of infectious disease transmission, failure of graft incorporation, and foreign-body reaction to the graft tissue.

    BTM is synthetic and so has no cross-species disease transfer risk and provides no food supply for bacteria. The BTM chambers compartmentalize the wound and create a physical barrier that aids in minimizing foreign body response. And to date, BTM has demonstrated very low levels of graft failure.

    I can see absolutely no reason why BTM couldn’t be adapted for use in shoulder surgery.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.41
Change
0.030(1.26%)
Mkt cap ! $1.663B
Open High Low Value Volume
$2.40 $2.41 $2.36 $3.091M 1.289M

Buyers (Bids)

No. Vol. Price($)
6 27741 $2.39
 

Sellers (Offers)

Price($) Vol. No.
$2.41 45108 5
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.